The GoodRx Prescription Savings Blog

The latest updates on prescription drugs and ways to save from the GoodRx medical team

The Six Billion Dollar Pill: Is Nexium Worth the Money?

by Dr. Sharon Orrange on November 21, 2013 at 11:02 am

Proton pump inhibitors (PPIs) work well for the treatment of heartburn, gastroesophageal reflux disease (GERD), and gastric ulcers. Nexium, a brand name PPI not available as a generic, made CC by Rennett Stoweover 6 billion dollars this past year with so many of you paying big money for it.

Why pay for Nexium? Proton pump inhibitors are available over the counter (Zegerid OTC, Prilosec OTC and Prevacid 24HR) as well as many prescription generic forms like pantoprazole (Protonix). So why would you pay for an expensive PPI when a cheaper one is available? I don’t know why. Nexium has never been shown to be superior to any of the other PPIs with the exception of a few drug-company sponsored studies which looked at “maintenance of healing of erosive esophagitis” and Nexium 20 mg edged out lansoprazole (Prevacid) 15 mg a day.

For the most part, all PPIs are created equally. It’s not just Nexium we can wonder about—Dexilant is another expensive brand name PPI—yet Nexium is still raking in an astounding 6 billion dollars a year because you (our patients) are buying it and we (some doctors) are prescribing it. Has the advertising gotten to us?

Just say no to expensive brand name drugs, when a good generic is available and essentially equivalent.

Dr O.

Copyright ©2015 GoodRx, Inc.

This information is for informational purposes only and is not meant to be a substitute for professional medical advice, diagnosis or treatment. GoodRx is not offering advice, recommending or endorsing any specific prescription drug, pharmacy or other information on the site. GoodRx provides no warranty for any of the pricing data or other information. Please seek medical advice before starting, changing or terminating any medical treatment. Third party logos, trademarks, brand names and images contained on are for demonstration purposes only and are owned by their respective rights holders, who are not affiliated with this Site.